A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection with Borrelia burgdorferi sensu lato. There is limited information available about the use of OspA vaccines in this population. In this study, a randomized double-bli...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Vaccine Immunol
Huvudupphovsmän: Wressnigg, Nina, Barrett, P. Noel, Pöllabauer, Eva-Maria, O'Rourke, Maria, Portsmouth, Daniel, Schwendinger, Michael G., Crowe, Brian A., Livey, Ian, Dvorak, Thomas, Schmitt, Bernhard, Zeitlinger, Markus, Kollaritsch, Herwig, Esen, Meral, Kremsner, Peter G., Jelinek, Tomas, Aschoff, Roland, Weisser, Roland, Naudts, Ingomar F. K., Aichinger, Gerald
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2014
Ämnen:
Vaccines
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4248771/
https://ncbi.nlm.nih.gov/pubmed/25185574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00406-14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk